TAT'YANA LOBODA: Open Payments
NPI 1831884196 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,641 in 44 payments from 18 companies in 2025. Trend: 2023 $98 · 2024 $347 · 2025 $1,641
Food & beverage: $1,156Education: $485
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $381 |
| Agios Pharmaceuticals, Inc. | 3 | $188 |
| Incyte Corporation | 5 | $173 |
| PFIZER INC. | 2 | $154 |
| AstraZeneca Pharmaceuticals LP | 6 | $147 |
| Astellas Pharma US Inc | 2 | $117 |
| SEAGEN INC. | 1 | $85 |
| Merck Sharp & Dohme LLC | 3 | $75 |
| Lilly USA, LLC | 2 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
Products named: PYRUKYND, DARZALEX, XTANDI, ERLEADA, KEYTRUDA, JAKAFI, TALVEY, ENHERTU.
Industry payments across CA — which companies pay providers there.
